G1 Therapeutics has failed to hit its target in a pivotal, late-stage trial and is signaling more layoffs ahead.
Zac Ezzone, Biz Journals
Tue, 06/25/2024 - 4:34am
G1 Therapeutics has failed to hit its target in a pivotal, late-stage trial and is signaling more layoffs ahead.